Stem Cell Oversight Committee

The Stem Cell Oversight Committee reviews research applications involving human pluripotent stem cells that have been derived from and embryonic source and/or will be transferred into humans or non-human animals to ensure compliance with Chapter 12, Section F of the TCPS 2 (2014).

Terms of Reference
Administrative resources


Jay M. Baltz
Associate Director and Senior Scientist
Ottawa Hospital Research Institute

Harold Atkins
Physician, Blood and Marrow Transplant Program
The Ottawa Hospital

Alain Beaudet
CIHR President
Ex officio, non voting member

Tania Bubela
Assistant Professor
Department of Public Health Sciences, School of Public Health
University of Alberta

Richard Gold
Full Professor
James McGill Professor
Associate member, McGill Department of Human Genetics

Zubin Master
Assistant Professor,
Alden March Bioethics Institute,
Albany Medical College

Walter Preugschas
Owner and Operator
Bloombury Farms

Barbara von Tigerstrom
Associate Professor
College of Law
University of Saskatchewan

Rosanna Weksberg
Professor, Pediatrics and Molecular Genetics
The Hospital for Sick Children and the University of Toronto

Peter Zandstra
University of Toronto
Institute of Biomaterials and Biomedical Engineering

Amy Zarzeczny
Assistant Professor
University of Regina’s Johnson-Shoyama Graduate School of Public Policy (JSGS)

Date modified: